Literature DB >> 11242148

HIV-1 genetic diversity in Galicia Spain: BG intersubtype recombinant viruses circulating among injecting drug users.

M M Thomson1, E Delgado, N Manjón, A Ocampo, M L Villahermosa, A Mariño, I Herrero, M T Cuevas, E Vázquez-de Parga, L Pérez-Alvarez, L Medrano, J A Taboada, R Nájera.   

Abstract

BACKGROUND: The HIV-1 epidemics in Western Europe are dominated by B subtype viruses. Non-B subtype is largely restricted to individuals infected outside of Europe and to their direct contacts and is generally acquired by the heterosexual route.
METHODS: Protease and a segment of reverse transcriptase were amplified and sequenced from plasma RNA in 451 individuals from seven cities of Galicia, north-western Spain. Subtype sequence homologies were determined using the BLAST algorithm. Non-B sequences were examined by phylogenetic analysis and intersubtype recombination by bootscanning. The env V3 region was analysed in all non-B and in 38 B subtype viruses.
RESULTS: Ten different non-B genetic forms were identified in 20 (4.4%) individuals. Subtypes were concordant between pol and V3 in five viruses; 14 (70%) infections were with intersubtype recombinant viruses, and one individual had a dual B+G infection. Seven recombinant viruses were phylogenetically related to five reported recombinant forms. Three non-recombinant G and six recombinant BG viruses formed a monophyletic cluster for pol. All but three individuals with non-B infections were native Spanish. Only 6 of 16 individuals referred to sexual contacts with sub-Saharan Africans. Twelve (60%) non-B subtype infections, including all with G and BG viruses, were in injecting drug users (IDU).
CONCLUSIONS: Non-B subtype viruses were identified in 4.4%, with a high diversity of genetic forms, including 70% infections with intersubtype recombinant viruses. The majority of individuals with non-B infections were IDU, most of them without known contacts with non-European sources, and among whom BG recombinant viruses are circulating.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11242148     DOI: 10.1097/00002030-200103090-00010

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  17 in total

1.  Evaluation of the clinical sensitivities of three viral load assays with plasma samples from a pediatric population predominantly infected with human immunodeficiency virus type 1 subtype G and BG recombinant forms.

Authors:  Rute Antunes; Sofia Figueiredo; Inês Bártolo; Manuel Pinheiro; Lino Rosado; Isabel Soares; Helena Lourenço; Nuno Taveira
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

2.  Field evaluation of the gag-based heteroduplex mobility assay for genetic subtyping of circulating recombinant forms of human immunodeficiency virus type 1 in Abidjan, Côte d'Ivoire.

Authors:  Souleymane Sawadogo; Christiane Adjé-Touré; Celestin E Bilé; Rene E A Ekpini; Terence Chorba; John N Nkengasong
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

3.  Nucleotide and amino acid polymorphisms at drug resistance sites in non-B-subtype variants of human immunodeficiency virus type 1.

Authors:  Dan Turner; Bluma Brenner; Daniela Moisi; Mervi Detorio; Raymond Cesaire; Takashi Kurimura; Haruyo Mori; Max Essex; Shlomo Maayan; Mark A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

4.  Human immunodeficiency virus type 1 superinfection was not detected following 215 years of injection drug user exposure.

Authors:  Rose Tsui; Belinda L Herring; Jason D Barbour; Robert M Grant; Peter Bacchetti; Alex Kral; Brian R Edlin; Eric L Delwart
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

5.  Patterns of feline immunodeficiency virus multiple infection and genome divergence in a free-ranging population of African lions.

Authors:  Jennifer L Troyer; Jill Pecon-Slattery; Melody E Roelke; Lori Black; Craig Packer; Stephen J O'Brien
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

6.  Dual lentivirus infection potentiates neuroinflammation and neurodegeneration: viral copassage enhances neurovirulence.

Authors:  Amir Afkhami-Goli; Shu-Hong Liu; Yu Zhu; Joseph M Antony; Hosseinali Arab; Christopher Power
Journal:  J Neurovirol       Date:  2009-04       Impact factor: 2.643

Review 7.  Overview of HIV molecular epidemiology among people who inject drugs in Europe and Asia.

Authors:  Georgios K Nikolopoulos; Evangelia-Georgia Kostaki; Dimitrios Paraskevis
Journal:  Infect Genet Evol       Date:  2016-06-07       Impact factor: 3.342

8.  Frequency of subtype B and F1 dual infection in HIV-1 positive, Brazilian men who have sex with men.

Authors:  Ana Carolina Soares de Oliveira; Rodrigo Pessôa de Farias; Antonio Charlys da Costa; Mariana Melillo Sauer; Katia Cristina Bassichetto; Solange Maria Santos Oliveira; Priscilla Ramos Costa; Claudia Tomiyama; Helena Tomoko Iwashita Tomiyama; Ester Cerdeira Sabino; Esper Georges Kallas; Sabri Saeed Sanabani
Journal:  Virol J       Date:  2012-09-29       Impact factor: 4.099

9.  Near full-length genome analysis of low prevalent human immunodeficiency virus type 1 subclade F1 in São Paulo, Brazil.

Authors:  Sabri Saeed Sanabani; Evelyn Regina de Souza Pastena; Walter Kleine Neto; Claudia C Barreto; Kelly T Ferrari; Erika M N Kalmar; Suzete Ferreira; Ester Cerdeira Sabino
Journal:  Virol J       Date:  2009-06-16       Impact factor: 4.099

10.  HIV transmission clusters among injecting drug users in Romania.

Authors:  Aura Temereanca; Cristiana Oprea; Joel O Wertheim; Irina Ianache; Emanoil Ceausu; Costin Cernescu; Sanjay R Mehta; Simona Ruta
Journal:  Rom Biotechnol Lett       Date:  2017 Jan-Feb
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.